Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition and Safety in Patients With Cervical Dystonia
Completed
- Conditions
- Cervical Dystonia
- Registration Number
- NCT02175693
- Lead Sponsor
- Eisai Co., Ltd.
- Brief Summary
Investigation of the clinical condition and safety in patients with cervical dystonia
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1647
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall assessments of the improvement in the seriousness of seizures Up to 3 years Improvement is based on the 5 following elements: 1) Eminent improvement 2) Improvement 3) Improvement a little invariability 5) Exacerbation 6) It is not possible to judge
- Secondary Outcome Measures
Name Time Method